Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Invest Radiol. 2021 Jun 1;56(6):374–384. doi: 10.1097/RLI.0000000000000752

Table 2.

Cytokines with a significant difference between GDD patients and healthy Flu vaccine controls1

Cytokine P-value, GDD vs. Control GDD Mean GDD SD Control Mean Control SD Difference in Means as Pct of Control Range P-value, Recent onset vs. Control Recent Onset Mean Recent Onset SD
MIP1D 0.000001 2803.6 1467.3 1023.9 517.5 72.8 0.001497 3009.2 1853.7
SCD40L 0.000001 1547.0 1389.4 3539.1 1495.6 −29.3 0.000031 1644.5 1116.4
CTACK 0.000007 6287.9 1386.1 4636.5 1149.3 33.5 0.000001 6755.6 1046.3
TRAIL 0.001790 202.2 47.8 158.3 57.8 15.7 0.026655 197.1 50.1
GCSF 0.001936 230.2 66.2 180.0 49.8 25.5 0.107031 219.4 80.8
PAI1 0.004547 25576.6 4070.5 28709.6 4229.3 −15.8 0.051418 26026.1 4110.5
EGF 0.004884 257.4 368.0 511.9 291.5 −24.2 0.000006 211.2 119.9
GROA 0.009568 6612.9 5920.8 3289.8 2341.9 34.7 0.053633 7107.3 6629.4
EOTAXIN2 0.019041 3295.5 2926.4 1786.6 1453.4 22.2 0.172307 2844.0 2615.0
HGF 0.037928 28.8 10.9 34.5 9.6 −14.1 0.000149 25.9 4.7
IFNA2 0.042243 24.4 5.9 28.4 9.2 −10.6 0.154038 24.9 6.7
IL12P70 0.042394 25.7 6.6 31.6 14.8 −10.3 0.142343 26.8 7.5
1

Columns include cytokine, the p-value for the comparison between GDD patients and controls, the mean levels and standard deviations for both GDD patients and controls, the difference in means between GDD patients and controls expressed as a percentage of the control range, the p-value of a comparison of recent onset GDD patients (≤ 2years) to the controls, and the mean levels and standard deviations for the recent onset GDD patients. P-values are from Student’s t-test.

2

Serum samples.